Skip to main content
FinSpry Logo
FinSpry
NBTX logo
NBTX
(NASDAQ)
Nanobiotix S.A.
$31.04-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Nanobiotix (NBTX) Stock Price & Financial Analysis

Nanobiotix Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$30.06 - $32.20
52-Week High$41.89
52-Week Low$2.99
Open$31.03
Volume98.74K
Average Volume (3M)98.74K
Market Cap1.47B
Shares Outstanding47.42M
Price to Sales (P/S)29.21
EV/EBITDA-25.43
Revenue (TTM)55.24M
Net Income (TTM)-98.06M
Free Cash Flow (TTM)-38.26M
EPS (TTM)$-2.07
Profit Margin-177.53%
Operating Margin-143.90%
50-Day MA$27.81
200-Day MA$18.13
52-Week Change851.68%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Nanobiotix

What is the current stock price for NBTX?

As of the latest trading session, NBTX stock trades at $31.04. The 52-week range is $2.99–$41.89, with a day range of $30.06–$32.20.

What is the P/E ratio for NBTX?

The P/E ratio (Price-to-Earnings) for NBTX is shown in the Key Statistics section. This valuation metric helps compare Nanobiotix S.A. to industry peers.

Does NBTX pay dividends?

Nanobiotix does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for NBTX?

Based on 1 analyst, the consensus for NBTX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of NBTX?

Nanobiotix's market capitalization is $1.47B, classifying it as a small-cap company. Nanobiotix operates in the Healthcare sector within the Biotechnology industry.